Results 151 to 160 of about 37,220 (200)

Exceptionally long-lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD-L1: A case report. [PDF]

Thorac Cancer
Inoue T, Kunimasa K, Tamiya M, Kawamura T, Minami T, Nishino K.   +5 more
europepmc   +1 more source

HIP1-ALK-Rearranged Lung Cancer in a Young Adult With BRAF V600E Mutation Detected After ALK Tyrosine Kinase Inhibitor Therapy: A Case Report. [PDF]

JTO Clin Res Rep
Ogimoto A, Katsurada N, Yatani A, Mimura C, Yamamoto M, Tachihara M.   +5 more
europepmc   +1 more source

Response to PD-1 inhibitor in SMARCB1‑deficient undifferentiated rectal carcinoma with low TMB, proficient MMR and BRAF V600E mutation: a case report and literature review. [PDF]

Diagn Pathol
Shen W, Pan Y, Zou S.
europepmc   +1 more source

Killing capacity analysis of tumor-infiltrating cytotoxic lymphocytes and impact on lymph node metastasis in differentiated papillary carcinoma of thyroid with the BRAF V600E mutation. [PDF]

Diagn Pathol
Liu X, Liu H, Wang L, Han Y, Kong L, Zhang X.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cerebellar Pleomorphic Xanthoastrocytoma with BRAF V600E Mutation

World Neurosurgery, 2020
Pleomorphic xanthoastrocytoma (PXA) is a rare type of astrocytoma with a peak incidence from 10 to 19 years of age. PXA is found most commonly in the supratentorium. When it is present in atypical areas such as the infratentorium, it is often overlooked as a potential differential diagnosis.This report discusses the case of an 18-year-old woman with a ...
Sang Ho Kim, Kihwan Hwang, Kyu Sang Lee, Gheeyoung Choe, Chae-Yong Kim   +4 more
openaire   +2 more sources

BRAF V600E Mutations in Endometrial Adenocarcinoma

Diagnostic Molecular Pathology, 2013
The BRAF V600E somatic mutation is recognized as an oncogenic driver of many human cancers involving the MAPK/ERK pathway. Colorectal and lung cancers associated with the BRAF V600E mutation often demonstrated mucinous morphology. This study hypothesized that the BRAF V600E mutation may be associated with mucinous morphology in endometrial cancer and ...
Mai, He, Virginia, Breese, Steven, Hang, Cunxian, Zhang, Jinjun, Xiong, Cynthia, Jackson   +5 more
openaire   +2 more sources

BRAF V600E mutation-specific antibody: A review

Seminars in Diagnostic Pathology, 2015
The significance of BRAF mutations in neoplasia was first recognized in 2002 when mutations were discovered in a broad range of cancers. Numerous subsequent studies expanded our understanding of BRAF V600E as a critical diagnostic, prognostic, and predictive biomarker in many cancers.
Lauren L, Ritterhouse, Justine A, Barletta   +1 more
openaire   +2 more sources